Back
Novo Nordisk A/S Vs. Apogee Enterprises, Inc. Industry Stock Comparison
Sell
48
NVO
Novo Nordisk A/S
Last Price:
$59.15
Seasonality Move:
5.97%
Sell
40
APOG
Apogee Enterprises, Inc.
Last Price:
$34.90
Seasonality Move:
5.5%
Sell
48
Novo Nordisk A/S (NVO)
is a Sell
Is Novo Nordisk A/S a Buy, Sell or Hold?
-
The current Novo Nordisk A/S [NVO] share price is $57.34. The Score for NVO is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Apogee Enterprises, Inc. (APOG)
is a Sell
Is Apogee Enterprises, Inc. a Buy, Sell or Hold?
-
The current Apogee Enterprises, Inc. [APOG] share price is $33.77. The Score for APOG is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
APOG is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NVO Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $57.34Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVO is experiencing slight selling pressure.
APOG Stock Price Chart
What is Apogee Enterprises, Inc.'s stock price today?
-
The Apogee Enterprises, Inc. share price today is $33.77Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APOG is experiencing slight buying pressure.
NVO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.84 | Buy |
| Relative Strength Index (14 RSI): | 72.6 | Buy |
| Chaikin Money Flow: | -4665319 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (47.51 - 53.67) | Buy |
| Bollinger Bands (100): | (48.72 - 57.26) | Buy |
APOG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.7 | Sell |
| Relative Strength Index (14 RSI): | 35.89 | Sell |
| Chaikin Money Flow: | 244445 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.92 - 39.76) | Sell |
| Bollinger Bands (100): | (35.93 - 43.19) | Sell |
NVO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.91 | Buy |
| 20-day SMA: | 51.41 | Buy |
| 50-day SMA: | 49.49 | Buy |
| 200-day SMA: | 59.34 | Sell |
| 8-day EMA: | 54.56 | Buy |
| 20-day EMA: | 52.2 | Buy |
| 50-day EMA: | 51.4 | Buy |
| 200-day EMA: | 61.96 | Sell |
APOG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.04 | Sell |
| 20-day SMA: | 37.95 | Sell |
| 50-day SMA: | 36.64 | Sell |
| 200-day SMA: | 40.8 | Sell |
| 8-day EMA: | 35.7 | Sell |
| 20-day EMA: | 36.87 | Sell |
| 50-day EMA: | 37.57 | Sell |
| 200-day EMA: | 42.57 | Sell |
Novo Nordisk A/S Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.14 per share, and an increase next year of $0.46 per share.
Apogee Enterprises, Inc. Earnings Growth & APOG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.18 per share, an increase next quarter of $0.12 per share, a decrease this year of $1.42 per share, and a decrease next year of $0.04 per share.
Novo Nordisk A/S Technical Analysis
| Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 29 | 30 | 31 | 02 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Apogee Enterprises, Inc. Technical Analysis
| Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 22 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||